Literature DB >> 24510657

Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study.

Mi-Ryung Han1, Sandra Deming-Halverson, Qiuyin Cai, Wanqing Wen, Martha J Shrubsole, Xiao-Ou Shu, Wei Zheng, Jirong Long.   

Abstract

BACKGROUND: Genome-wide association studies have discovered multiple genetic loci associated with breast cancer risk. Investigating these loci would be helpful to evaluate previous findings and identify causal variants for breast cancer. We evaluated index SNPs in 17 of these loci in a study of 1,511 cases and 1,454 controls of European descent.
METHODS: We investigated the overall association with breast cancer and among subtypes defined as ER+ (estrogen receptor positive), ER- (estrogen receptor negative) and triple-negative breast cancer (TNBC). Combined effects of SNPs on breast cancer risk were assessed via a genetic risk score. We evaluated the contribution of both genetic variants and traditional risk factors to a breast cancer risk assessment model.
RESULTS: Five of the 17 SNPs were significantly associated (P ≤ 0.05) with overall breast cancer in the same direction as previously reported: rs13387042 (2q35/TNP1), rs4973768 (3p24/SLC4A7), rs2046210 (6q25/ESR1), rs1219648 (10q26/FGFR2), and rs4784227 (16q12/TOX3). When stratified by breast cancer subtype, all five SNPs were associated (P < 0.05) with ER+ cancer, three with ER- cancer (rs13387042, rs1219648, and rs4784227), and one with TNBC (rs1219648). A GRS, based on those five significant SNPs, showed strong association with overall breast cancer with ORs (95 % CI) of 1.48 (1.22-1.79), 1.85 (1.52-2.25) and 2.26 (1.82-2.80), respectively, for each quartile, (P = 2.0 × 10(-15)). Traditional risk factors, including previous benign breast disease, breast cancer family history and parity, were significantly associated with breast cancer risk in the present study. These factors, together with the GRS, were used to build a breast cancer risk assessment model with a c statistic of 0.6321 from receiver operating characteristic analysis. The contribution of the GRS to the model was greater than prior benign breast disease, family history and parity with the c statistic change of 0.0374, 0.0324, 0.0103, 0.0012, respectively.
CONCLUSIONS: Our study demonstrates that five SNPs were associated with overall breast cancer, with stronger association for ER+ than ER- cancer as previously reported, and suggests that a risk assessment model incorporating the GRS from five loci is useful in identifying women at high risk of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510657      PMCID: PMC4127164          DOI: 10.1007/s12282-014-0518-2

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  16 in total

Review 1.  Breast cancer genetics: what we know and what we need.

Authors:  K L Nathanson; R Wooster; B L Weber; K N Nathanson
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.

Authors:  David J Hunter; Peter Kraft; Kevin B Jacobs; David G Cox; Meredith Yeager; Susan E Hankinson; Sholom Wacholder; Zhaoming Wang; Robert Welch; Amy Hutchinson; Junwen Wang; Kai Yu; Nilanjan Chatterjee; Nick Orr; Walter C Willett; Graham A Colditz; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; Richard B Hayes; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert N Hoover; Gilles Thomas; Stephen J Chanock
Journal:  Nat Genet       Date:  2007-05-27       Impact factor: 38.330

3.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.

Authors:  Simon N Stacey; Andrei Manolescu; Patrick Sulem; Thorunn Rafnar; Julius Gudmundsson; Sigurjon A Gudjonsson; Gisli Masson; Margret Jakobsdottir; Steinunn Thorlacius; Agnar Helgason; Katja K Aben; Luc J Strobbe; Marjo T Albers-Akkers; Dorine W Swinkels; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Esther Millastre; Raquel Andres; Javier Godino; Maria Dolores Garcia-Prats; Eduardo Polo; Alejandro Tres; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Larus Gudmundsson; Kristleifur Kristjansson; Jon T Bergthorsson; Jelena Kostic; Michael L Frigge; Frank Geller; Daniel Gudbjartsson; Helgi Sigurdsson; Thora Jonsdottir; Jon Hrafnkelsson; Jakob Johannsson; Thorarinn Sveinsson; Gardar Myrdal; Hlynur Niels Grimsson; Thorvaldur Jonsson; Susanna von Holst; Barbro Werelius; Sara Margolin; Annika Lindblom; Jose I Mayordomo; Christopher A Haiman; Lambertus A Kiemeney; Oskar Th Johannsson; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-05-27       Impact factor: 38.330

4.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.

Authors:  Bert Gold; Tomas Kirchhoff; Stefan Stefanov; James Lautenberger; Agnes Viale; Judy Garber; Eitan Friedman; Steven Narod; Adam B Olshen; Peter Gregersen; Kristi Kosarin; Adam Olsh; Julie Bergeron; Nathan A Ellis; Robert J Klein; Andrew G Clark; Larry Norton; Michael Dean; Jeff Boyd; Kenneth Offit
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-07       Impact factor: 11.205

5.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

Review 6.  The genetics and genomics of cancer.

Authors:  Allan Balmain; Joe Gray; Bruce Ponder
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

7.  Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

Authors:  Wei Zheng; Jirong Long; Yu-Tang Gao; Chun Li; Ying Zheng; Yong-Bin Xiang; Wanqing Wen; Shawn Levy; Sandra L Deming; Jonathan L Haines; Kai Gu; Alecia Malin Fair; Qiuyin Cai; Wei Lu; Xiao-Ou Shu
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

8.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.

Authors:  Simon N Stacey; Andrei Manolescu; Patrick Sulem; Steinunn Thorlacius; Sigurjon A Gudjonsson; Gudbjörn F Jonsson; Margret Jakobsdottir; Jon T Bergthorsson; Julius Gudmundsson; Katja K Aben; Luc J Strobbe; Dorine W Swinkels; K C Anton van Engelenburg; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Esther Millastre; Raquel Andres; Berta Saez; Julio Lambea; Javier Godino; Eduardo Polo; Alejandro Tres; Simone Picelli; Johanna Rantala; Sara Margolin; Thorvaldur Jonsson; Helgi Sigurdsson; Thora Jonsdottir; Jon Hrafnkelsson; Jakob Johannsson; Thorarinn Sveinsson; Gardar Myrdal; Hlynur Niels Grimsson; Steinunn G Sveinsdottir; Kristin Alexiusdottir; Jona Saemundsdottir; Asgeir Sigurdsson; Jelena Kostic; Larus Gudmundsson; Kristleifur Kristjansson; Gisli Masson; James D Fackenthal; Clement Adebamowo; Temidayo Ogundiran; Olufunmilayo I Olopade; Christopher A Haiman; Annika Lindblom; Jose I Mayordomo; Lambertus A Kiemeney; Jeffrey R Gulcher; Thorunn Rafnar; Unnur Thorsteinsdottir; Oskar T Johannsson; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

9.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

Authors:  Shahana Ahmed; Gilles Thomas; Maya Ghoussaini; Catherine S Healey; Manjeet K Humphreys; Radka Platte; Jonathan Morrison; Melanie Maranian; Karen A Pooley; Robert Luben; Diana Eccles; D Gareth Evans; Olivia Fletcher; Nichola Johnson; Isabel dos Santos Silva; Julian Peto; Michael R Stratton; Nazneen Rahman; Kevin Jacobs; Ross Prentice; Garnet L Anderson; Aleksandar Rajkovic; J David Curb; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; W Ryan Diver; Stig Bojesen; Børge G Nordestgaard; Henrik Flyger; Thilo Dörk; Peter Schürmann; Peter Hillemanns; Johann H Karstens; Natalia V Bogdanova; Natalia N Antonenkova; Iosif V Zalutsky; Marina Bermisheva; Sardana Fedorova; Elza Khusnutdinova; Daehee Kang; Keun-Young Yoo; Dong Young Noh; Sei-Hyun Ahn; Peter Devilee; Christi J van Asperen; R A E M Tollenaar; Caroline Seynaeve; Montserrat Garcia-Closas; Jolanta Lissowska; Louise Brinton; Beata Peplonska; Heli Nevanlinna; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; John L Hopper; Melissa C Southey; Letitia Smith; Amanda B Spurdle; Marjanka K Schmidt; Annegien Broeks; Richard R van Hien; Sten Cornelissen; Roger L Milne; Gloria Ribas; Anna González-Neira; Javier Benitez; Rita K Schmutzler; Barbara Burwinkel; Claus R Bartram; Alfons Meindl; Hiltrud Brauch; Christina Justenhoven; Ute Hamann; Jenny Chang-Claude; Rebecca Hein; Shan Wang-Gohrke; Annika Lindblom; Sara Margolin; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Janet E Olson; Xianshu Wang; Zachary Fredericksen; Graham G Giles; Gianluca Severi; Laura Baglietto; Dallas R English; Susan E Hankinson; David G Cox; Peter Kraft; Lars J Vatten; Kristian Hveem; Merethe Kumle; Alice Sigurdson; Michele Doody; Parveen Bhatti; Bruce H Alexander; Maartje J Hooning; Ans M W van den Ouweland; Rogier A Oldenburg; Mieke Schutte; Per Hall; Kamila Czene; Jianjun Liu; Yuqing Li; Angela Cox; Graeme Elliott; Ian Brock; Malcolm W R Reed; Chen-Yang Shen; Jyh-Cherng Yu; Giu-Cheng Hsu; Shou-Tung Chen; Hoda Anton-Culver; Argyrios Ziogas; Irene L Andrulis; Julia A Knight; Jonathan Beesley; Ellen L Goode; Fergus Couch; Georgia Chenevix-Trench; Robert N Hoover; Bruce A J Ponder; David J Hunter; Paul D P Pharoah; Alison M Dunning; Stephen J Chanock; Douglas F Easton
Journal:  Nat Genet       Date:  2009-03-29       Impact factor: 38.330

10.  Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.

Authors:  Montserrat Garcia-Closas; Per Hall; Heli Nevanlinna; Karen Pooley; Jonathan Morrison; Douglas A Richesson; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Jose I Arias; Roger L Milne; Gloria Ribas; Anna González-Neira; Javier Benítez; Pilar Zamora; Hiltrud Brauch; Christina Justenhoven; Ute Hamann; Yon-Dschun Ko; Thomas Bruening; Susanne Haas; Thilo Dörk; Peter Schürmann; Peter Hillemanns; Natalia Bogdanova; Michael Bremer; Johann Hinrich Karstens; Rainer Fagerholm; Kirsimari Aaltonen; Kristiina Aittomäki; Karl von Smitten; Carl Blomqvist; Arto Mannermaa; Matti Uusitupa; Matti Eskelinen; Maria Tengström; Veli-Matti Kosma; Vesa Kataja; Georgia Chenevix-Trench; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Peter Devilee; Christi J van Asperen; Catharina E Jacobi; Rob A E M Tollenaar; Petra E A Huijts; Jan G M Klijn; Jenny Chang-Claude; Silke Kropp; Tracy Slanger; Dieter Flesch-Janys; Elke Mutschelknauss; Ramona Salazar; Shan Wang-Gohrke; Fergus Couch; Ellen L Goode; Janet E Olson; Celine Vachon; Zachary S Fredericksen; Graham G Giles; Laura Baglietto; Gianluca Severi; John L Hopper; Dallas R English; Melissa C Southey; Christopher A Haiman; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Daniel O Stram; David J Hunter; Susan E Hankinson; David G Cox; Rulla Tamimi; Peter Kraft; Mark E Sherman; Stephen J Chanock; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Jan G M Klijn; Maartje J Hooning; Han Meijers-Heijboer; J Margriet Collee; Ans van den Ouweland; Andre G Uitterlinden; Jianjun Liu; Low Yen Lin; Li Yuqing; Keith Humphreys; Kamila Czene; Angela Cox; Sabapathy P Balasubramanian; Simon S Cross; Malcolm W R Reed; Fiona Blows; Kristy Driver; Alison Dunning; Jonathan Tyrer; Bruce A J Ponder; Suleeporn Sangrajrang; Paul Brennan; James McKay; Fabrice Odefrey; Valerie Gabrieau; Alice Sigurdson; Michele Doody; Jeffrey P Struewing; Bruce Alexander; Douglas F Easton; Paul D Pharoah
Journal:  PLoS Genet       Date:  2008-04-25       Impact factor: 5.917

View more
  8 in total

1.  Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population.

Authors:  Xu Li; Wenjing Zou; Ming Liu; Wei Cao; Yonghong Jiang; Gaili An; Yuzheng Wang; Shangke Huang; Xinhan Zhao
Journal:  Oncotarget       Date:  2016-12-20

2.  Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1.

Authors:  Yaqiong Sun; Chuanzhong Ye; Xingyi Guo; Wanqing Wen; Jirong Long; Yu-Tang Gao; Xiao Ou Shu; Wei Zheng; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2015-12-08       Impact factor: 4.944

Review 3.  Mouse models of SLC4-linked disorders of HCO3--transporter dysfunction.

Authors:  Mark D Parker
Journal:  Am J Physiol Cell Physiol       Date:  2018-01-31       Impact factor: 4.249

4.  A family-based, genome-wide association study of young-onset breast cancer: inherited variants and maternally mediated effects.

Authors:  Katie M O'Brien; Min Shi; Dale P Sandler; Jack A Taylor; Dmitri V Zaykin; Jean Keller; Alison S Wise; Clarice R Weinberg
Journal:  Eur J Hum Genet       Date:  2016-02-17       Impact factor: 4.246

5.  Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.

Authors:  Weifeng Tang; Yuanmei Chen; Yafeng Wang; Haiyong Gu; Shuchen Chen; Mingqiang Kang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.

Authors:  Yan Liu; Michelle Baglia; Ying Zheng; William Blot; Ping-Ping Bao; Hui Cai; Sarah Nechuta; Wei Zheng; Qiuyin Cai; Xiao Ou Shu
Journal:  Oncotarget       Date:  2015-12-01

7.  Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.

Authors:  Michelle Rath; Qiyuan Li; Huili Li; Sara Lindström; Alexander Miron; Penelope Miron; Anne E Dowton; Meghan E Meyer; Bryce G Larson; Mark Pomerantz; Ji-Heui Seo; Laura C Collins; Hilde Vardeh; Elena Brachtel; Steven E Come; Virginia Borges; Lidia Schapira; Rulla M Tamimi; Ann H Partridge; Matthew Freedman; Kathryn J Ruddy
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

Review 8.  Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer.

Authors:  Haipeng Lei; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2017-09-05       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.